Abstract
New-onset refractory status epilepticus (NORSE) is an increasingly recognized syndrome requiring aggressive antiepileptic management. A wide range of etiologies are associated with NORSE, including atypical infections and antibody mediated disorders [1].
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have